Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y L Han

Showing results (31-40 of 148) with videos related to

Pageof 15
Sort By:
Zhonghua Xin Xue Guan Bing Za Zhi|December 20, 2023
[Emergency coronary intervention treatment for acute myocardial infarction: reach back on the past 40 years]Y L Han, Y Li
Zhonghua Xin Xue Guan Bing Za Zhi|August 18, 2022
[Executive summary and interpretation on the update points of 2022 AHA/ACC/HFSA guideline for the management of heart failure]Z L Wang, Y L Han
Zhonghua Fu Chan Ke Za Zhi|July 1, 1986
[Rhabdomyosarcoma of the female genitalia]J J Peng, Y L Han
Zhonghua Xin Xue Guan Bing Za Zhi|March 2, 2019
[New choice of lipid-lowering therapy:PCSK9 inhibitors]Y Y Ma, Y L Han
Zhonghua Xin Xue Guan Bing Za Zhi|February 15, 2023
[Interventional strategy for left main artery disease: comprehensive evaluation, shared decision-making, and procedural considerations]H B Yan, Y L Han
Zhonghua Xin Xue Guan Bing Za Zhi|March 27, 2022
[Simultaneous percutaneous closure of left atrial appendage and patent foramen ovale: more than enough is too much?]Z L Wang, Y L Han
Zhonghua Xin Xue Guan Bing Za Zhi|December 14, 2022
[Interpretation on the new sections and some update points of 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death]Z L Wang, Y L Han
Zhonghua Xin Xue Guan Bing Za Zhi|September 18, 2024
[Keeping abreast of the times, the Chinese guidelines for the diagnosis and management of chronic coronary syndrome]P M Liu, Y L Han
Zhonghua Xin Xue Guan Bing Za Zhi|March 21, 2024
[Improving the prognosis of critical myocardial infarct patients: still a long way to go]H B Yan, Y L Han
Zhonghua Xin Xue Guan Bing Za Zhi|February 22, 2021
[Recent advances in antithrombotic therapy for patients with coronary artery disease undergoing percutaneous coronary intervention]H W Liu, Y L Han
Pageof 15

Showing results (31-40 of 148) with videos related to

Sort By:
Pageof 15
Zhonghua Xin Xue Guan Bing Za Zhi|December 20, 2023
[Emergency coronary intervention treatment for acute myocardial infarction: reach back on the past 40 years]Y L Han, Y Li
Zhonghua Xin Xue Guan Bing Za Zhi|August 18, 2022
[Executive summary and interpretation on the update points of 2022 AHA/ACC/HFSA guideline for the management of heart failure]Z L Wang, Y L Han
Zhonghua Fu Chan Ke Za Zhi|July 1, 1986
[Rhabdomyosarcoma of the female genitalia]J J Peng, Y L Han
Zhonghua Xin Xue Guan Bing Za Zhi|March 2, 2019
[New choice of lipid-lowering therapy:PCSK9 inhibitors]Y Y Ma, Y L Han
Zhonghua Xin Xue Guan Bing Za Zhi|February 15, 2023
[Interventional strategy for left main artery disease: comprehensive evaluation, shared decision-making, and procedural considerations]H B Yan, Y L Han
Zhonghua Xin Xue Guan Bing Za Zhi|March 27, 2022
[Simultaneous percutaneous closure of left atrial appendage and patent foramen ovale: more than enough is too much?]Z L Wang, Y L Han
Zhonghua Xin Xue Guan Bing Za Zhi|December 14, 2022
[Interpretation on the new sections and some update points of 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death]Z L Wang, Y L Han
Zhonghua Xin Xue Guan Bing Za Zhi|September 18, 2024
[Keeping abreast of the times, the Chinese guidelines for the diagnosis and management of chronic coronary syndrome]P M Liu, Y L Han
Zhonghua Xin Xue Guan Bing Za Zhi|March 21, 2024
[Improving the prognosis of critical myocardial infarct patients: still a long way to go]H B Yan, Y L Han
Zhonghua Xin Xue Guan Bing Za Zhi|February 22, 2021
[Recent advances in antithrombotic therapy for patients with coronary artery disease undergoing percutaneous coronary intervention]H W Liu, Y L Han
Pageof 15